ACADIAN ASSET MANAGEMENT LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 65 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$2,367,000
+40.6%
732,669
-7.8%
0.01%
+28.6%
Q4 2020$1,684,000
+122.2%
794,586
+22.7%
0.01%
+133.3%
Q3 2020$758,000
+40.6%
647,394
+8.6%
0.00%
+50.0%
Q2 2020$539,000
+9.3%
595,912
+1.2%
0.00%
-33.3%
Q1 2020$493,000
-19.0%
588,874
-7.1%
0.00%0.0%
Q4 2019$609,000
-4.8%
633,610
+2.1%
0.00%0.0%
Q3 2019$640,000
-40.9%
620,845
+3.2%
0.00%
-40.0%
Q2 2019$1,083,000
+6.2%
601,517
+10.9%
0.01%
+25.0%
Q1 2019$1,020,000
+79.3%
542,519
+12.5%
0.00%
+33.3%
Q4 2018$569,000
-40.8%
482,136
+36.0%
0.00%
-25.0%
Q3 2018$961,000
+35.2%
354,466
-4.7%
0.00%
+33.3%
Q2 2018$711,000
+77.8%
372,009
+95.2%
0.00%
+50.0%
Q1 2018$400,000
+506.1%
190,573
+485.2%
0.00%
Q4 2017$66,000
+34.7%
32,566
-11.9%
0.00%
Q3 2017$49,000
-83.7%
36,984
-80.8%
0.00%
-100.0%
Q2 2017$301,000
-84.1%
192,276
-67.1%
0.00%
-88.9%
Q1 2017$1,888,000
+1769.3%
585,232
+689.0%
0.01%
Q4 2016$101,000
-52.6%
74,175
-45.9%
0.00%
-100.0%
Q3 2016$213,000
-52.2%
137,093
-59.1%
0.00%
-50.0%
Q2 2016$446,000
-72.9%
335,203
+7.6%
0.00%
-75.0%
Q1 2016$1,643,000
-64.1%
311,639
-46.5%
0.01%
-66.7%
Q4 2015$4,571,000
-47.6%
582,278
-43.6%
0.02%
-50.0%
Q3 2015$8,718,000
-36.4%
1,031,894
-17.5%
0.05%
-27.3%
Q2 2015$13,705,000
+26.4%
1,251,479
+61.3%
0.07%
+32.0%
Q1 2015$10,844,000
+195.7%
775,732
+257.5%
0.05%
+212.5%
Q4 2014$3,667,000217,0140.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders